Hemophagocytic lymphohistiocytosis during treatment of intracranial multifocal germinoma: a case report and literature review

0Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.

Abstract

Hemophagocytic lymphohistiocytosis (HLH), also known as hemophagocytic syndrome (HPS), is a benign histiocytosis with hyperreactive proliferation of the mononuclear phagocyte system caused by immune function abnormalities, which often occurs under the background of genetic mutations, inflammation, infection or tumors. Because the research on malignancy-associated HLH (M-HLH) is focused on hematological malignancies, reports on HLH secondary to solid tumors are rare. In this case, we report a 14-year-old girl who developed HLH during treatment for intracranial multifocal germinoma, and the disease was controlled after hormone combined with etoposide(VP-16) and other related treatments. To our knowledge, there have been no documented cases of HLH caused by intracranial multifocal germinoma.

Cite

CITATION STYLE

APA

Guo, T., Liu, Z., Chen, Y., Cheng, Y., He, K., Lin, X., … Sun, Y. (2024). Hemophagocytic lymphohistiocytosis during treatment of intracranial multifocal germinoma: a case report and literature review. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1264926

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free